PF-04523655
Showing 1 - 25 of 1,081
Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet
Not yet recruiting
- Healthy Participants
- Single dose of PF-07220060 as first Tablet Formulation
- +3 more
- (no location specified)
Jun 20, 2023
Atopic Dermatitis Trial in United States (PF-07275315, PF-07264660, Placebo)
Not yet recruiting
- Atopic Dermatitis
- PF-07275315
- +2 more
-
Huntington Beach, California
- +3 more
Aug 21, 2023
Hemiparesis;Poststroke/CVA Trial in Créteil (Eccentric training, Conventional therapy)
Recruiting
- Hemiparesis;Poststroke/CVA
- Eccentric training
- Conventional therapy
-
Créteil, FranceWael Maktouf
Nov 16, 2023
Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)
Not yet recruiting
- Pulmonary Arterial Hypertension
- PF-07868489
- Placebo for PF-07868489
- (no location specified)
Nov 14, 2023
Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)
Not yet recruiting
- Breast Cancer
- +5 more
- PF-07224826
- Fulvestrant
- (no location specified)
Jun 7, 2023
Hemolysis During Pulsed-field and Radiofrequency Ablation
Not yet recruiting
- Atrial Fibrillation
- +2 more
- Pulsed-field ablation
- Radiofrequency ablation
-
Prague, CzechiaCardiocenter, 3rd Medical School, Charles University and Univers
Oct 20, 2023
Healthy Trial in New Haven (PF-07328948, Placebo)
Recruiting
- Healthy
- PF-07328948
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 5, 2023
Pelvic Floor Disorders Trial in Palma De Mallorca (Pelvic floor muscle training with biofeedback device, Pelvic floor muscle
Not yet recruiting
- Pelvic Floor Disorders
- Pelvic floor muscle training with biofeedback device
- +2 more
-
Palma De Mallorca, Balearic Islands, SpainUniversity of the Balearic Islands
Aug 29, 2023
Presbyopia Trial in Crystal River (BRIMOCHOL™ PF, Carbachol PF, Vehicle)
Recruiting
- Presbyopia
- BRIMOCHOL™ PF
- +2 more
-
Chandler, Arizona
- +42 more
Sep 30, 2022
Overweight, Obesity Trial in New Haven (Formulation A (PF-07081532 20 mg plus 60 mg), Formulation B (PF-07081532 80 mg))
Recruiting
- Overweight
- Obesity
- Formulation A (PF-07081532 20 mg plus 60 mg)
- Formulation B (PF-07081532 80 mg)
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jan 25, 2023
Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,
Recruiting
- Breast Cancer
- Solid Tumors
- PF-07220060 + PF-07104091 combination dose escalation
- +2 more
-
Grand Rapids, Michigan
- +1 more
Jun 28, 2022
Renal Impairment Trial (Drug: PF-07923568)
Not yet recruiting
- Renal Impairment
- Drug: PF-07923568
- (no location specified)
Sep 7, 2023
Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer,
Recruiting
- Locally Advanced or Metastatic ER+ HER2- Breast Cancer
- +2 more
- PF-07248144
- +3 more
-
Scottsdale, Arizona
- +45 more
Dec 11, 2022
Crohn's Disease Trial in Worldwide (PF-06651600 Placebo, PF-06651600, Placebo PF-06700841)
Active, not recruiting
- Crohn's Disease
- PF-06651600 Placebo
- +3 more
-
Dothan, Alabama
- +187 more
Aug 17, 2022
Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)
Recruiting
- Advanced Solid Tumors
- +5 more
- PF-07265028
- Sasanlimab
-
Scottsdale, Arizona
- +7 more
Jan 23, 2023
Plantar Fasciitis Trial in Boston (Orthotic)
Terminated
- Plantar Fasciitis
- Orthotic
-
Boston, MassachusettsMassachusetts General Hospital
Oct 31, 2023
Healthy Participants Trial in Brussels (PF-07258669, Placebo, Midazolam)
Recruiting
- Healthy Participants
- PF-07258669
- +2 more
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Nov 28, 2022
Complicated Intra-abdominal Infection Trial in Japan (PF-06947386, Metronidazole)
Completed
- Complicated Intra-abdominal Infection
-
Nagoya, Aichi, Japan
- +26 more
Nov 21, 2022
Progressive Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic
Not yet recruiting
- Progressive Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
- (no location specified)
Jul 5, 2023
Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)
Recruiting
- Interstitial Lung Diseases
- Anlotinib
- Placebo
-
Wenzhou, Zhejiang, ChinaThe First Affiliated Hospital of Wenzhou Medical University
Apr 13, 2023